Management of bleeding in patients taking FXa and FIIa inhibitors

被引：6

作者：

Keeling, David ^{[1
]}

Cotter, Finbarr ^{[2
]}

机构：

[1] Oxford Univ Hosp, Oxford Haemophilia & Thrombosis Ctr, Oxford, England

[2] Barts & London Queen Marys Sch Med & Dent, Ctr Haematooncol, Barts Canc Inst, London, England

来源：

BRITISH JOURNAL OF HAEMATOLOGY | 2013年 / 160卷 / 01期

关键词：

FACTOR XA; REVERSAL; DABIGATRAN; FEIBA(R); THROMBIN;

D O I：

10.1111/bjh.12106

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

引用

页码：1 / 2

页数：2

共 14 条

[1] The status of new anticoagulants [J].

Bates, Shannon M. ;

Weitz, Jeffrey I. .

BRITISH JOURNAL OF HAEMATOLOGY, 2006, 134 (01) :3-19

[2] Reversal of Rivaroxaban and Dabigatran by Prothrombin Complex Concentrate A Randomized, Placebo-Controlled, Crossover Study in Healthy Subjects [J].

Eerenberg, Elise S. ;

Kamphuisen, Pieter W. ;

Sijpkens, Meertien K. ;

Meijers, Joost C. ;

Buller, Harry R. ;

Levi, Marcel .

CIRCULATION, 2011, 124 (14) :1573-1579

[3] The new oral anticoagulants [J].

Garcia, David ;

Libby, Edward ;

Crowther, Mark A. .

BLOOD, 2010, 115 (01) :15-20

[4] First 20 years with recombinant FVIIa (NovoSeven) [J].

Hedner, U. ;

Lee, C. A. .

HAEMOPHILIA, 2011, 17 (01) :E172-E182

[5] Guidance on the emergent reversal of oral thrombin and factor Xa inhibitors [J].

Kaatz, Scott ;

Kouides, Peter A. ;

Garcia, David A. ;

Spyropolous, Alex C. ;

Crowther, Mark ;

Douketis, Jim D. ;

Chan, Anthony K. C. ;

James, Andra ;

Moll, Stephan ;

Ortel, Thomas L. ;

Van Cott, Elizabeth M. ;

Ansell, Jack .

AMERICAN JOURNAL OF HEMATOLOGY, 2012, 87 :S141-S145

[6] Guidelines on oral anticoagulation with warfarin - fourth edition [J].

Keeling, David ;

Baglin, Trevor ;

Tait, Campbell ;

Watson, Henry ;

Perry, David ;

Baglin, Caroline ;

Kitchen, Steve ;

Makris, Michael .

BRITISH JOURNAL OF HAEMATOLOGY, 2011, 154 (03) :311-324

[7] Bleeding risk and reversal strategies for old and new anticoagulants and antiplatelet agents [J].

Levi, M. ;

Eerenberg, E. ;

Kamphuisen, P. W. .

JOURNAL OF THROMBOSIS AND HAEMOSTASIS, 2011, 9 (09) :1705-1712

[8] FEIBA® safety profile in multiple modes of clinical and home-therapy application [J].

Luu, H ;

Ewenstein, B .

HAEMOPHILIA, 2004, 10 :10-16

[9] Guideline on the management of bleeding in patients on antithrombotic agents [J].

Makris, Mike ;

Van Veen, Joost J. ;

Tait, Campbell R. ;

Mumford, Andrew D. ;

Laffan, Mike .

BRITISH JOURNAL OF HAEMATOLOGY, 2013, 160 (01) :35-46

[10] Effect of non-specific reversal agents on anticoagulant activity of dabigatran and rivaroxaban [J].

Marlu, Raphael ;

Hodaj, Enkelejda ;

Paris, Adeline ;

Albaladejo, Pierre ;

Crackowski, Jean Luc ;

Pernod, Gilles .

THROMBOSIS AND HAEMOSTASIS, 2012, 108 (02) :217-224

← 1 2 →